Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2020 Filed Feb 26, 2020 21:15 UTC |
Wilson MarcCFO and Secretary
|
GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $22.61 | $0.00 |
DisclosureSEC source: 0001209191-20-012987 · doc4.xml · derivative · entry 1 Wilson Marc · CIK 0001702265 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2030-02-23 F1 · derivative.exercise_date: The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 24, 2020. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:18 UTC |
Krasner Alan SethChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $22.61 | $0.00 |
DisclosureSEC source: 0001209191-20-012997 · doc4.xml · derivative · entry 1 Krasner Alan Seth · CIK 0001435775 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-02-23 F1 · derivative.exercise_date: The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 24, 2020. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 5,904 | $21.40 | $126,345.60 |
DisclosureSEC source: 0001213900-20-003326 · ownership.xml · nonDerivative · entry 6 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 168,298 F7 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.4 to $21.6, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4 F3 · ownership.nature: These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF"). F5 · ownership.nature: Vivo Opportunity, LLC is the general partner of VOF. The voting members of Vivo Opportunity, LLC are Albert Cha, Gaurav Aggarwal, Shan Fu, Frank Kung and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 200 | $21.40 | $4,280.00 |
DisclosureSEC source: 0001213900-20-003326 · ownership.xml · nonDerivative · entry 5 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 375,928 F7 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.4 to $21.6, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4 F2 · ownership.nature: These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 1,451 | $21.40 | $31,051.40 |
DisclosureSEC source: 0001213900-20-003326 · ownership.xml · nonDerivative · entry 4 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 2,722,392 F7 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.4 to $21.6, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4 F1 · ownership.nature: These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| February 07, 2020 Filed Feb 12, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 4,614 | $22.00 | $101,508.00 |
DisclosureSEC source: 0001213900-20-003326 · ownership.xml · nonDerivative · entry 3 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 174,202 F6 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.9 to $22.2, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. F3 · ownership.nature: These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF"). F5 · ownership.nature: Vivo Opportunity, LLC is the general partner of VOF. The voting members of Vivo Opportunity, LLC are Albert Cha, Gaurav Aggarwal, Shan Fu, Frank Kung and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| February 07, 2020 Filed Feb 12, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 157 | $22.00 | $3,454.00 |
DisclosureSEC source: 0001213900-20-003326 · ownership.xml · nonDerivative · entry 2 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 376,128 F6 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.9 to $22.2, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. F2 · ownership.nature: These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| February 07, 2020 Filed Feb 12, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 1,134 | $22.00 | $24,948.00 |
DisclosureSEC source: 0001213900-20-003326 · ownership.xml · nonDerivative · entry 1 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 2,723,843 F6 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.9 to $22.2, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. F1 · ownership.nature: These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 00:22 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 10,519 | $22.80 | $239,833.20 |
DisclosureSEC source: 0001213900-20-002831 · ownership.xml · nonDerivative · entry 3 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 178,816 F6 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.2 to $23.0, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. F3 · ownership.nature: These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF"). F5 · ownership.nature: Vivo Opportunity, LLC is the general partner of VOF. The voting members of Vivo Opportunity, LLC are Albert Cha, Gaurav Aggarwal, Shan Fu, Frank Kung and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 00:22 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 357 | $22.80 | $8,139.60 |
DisclosureSEC source: 0001213900-20-002831 · ownership.xml · nonDerivative · entry 2 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 376,285 F6 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.2 to $23.0, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. F2 · ownership.nature: These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 00:22 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 2,584 | $22.80 | $58,915.20 |
DisclosureSEC source: 0001213900-20-002831 · ownership.xml · nonDerivative · entry 1 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnotes Disclosed balance after: 2,724,977 F6 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.2 to $23.0, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. F1 · ownership.nature: These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| January 31, 2020 Filed Feb 1, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 4,220 | $21.70 | $91,574.00 |
DisclosureSEC source: 0001213900-20-002314 · ownership.xml · nonDerivative · entry 9 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 189,335 F8 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.2 to $22.0, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (8) to this Form 4. F3 · ownership.nature: These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF"). F5 · ownership.nature: Vivo Opportunity, LLC is the general partner of VOF. The voting members of Vivo Opportunity, LLC are Albert Cha, Gaurav Aggarwal, Shan Fu, Frank Kung and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| January 31, 2020 Filed Feb 1, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 143 | $21.70 | $3,103.10 |
DisclosureSEC source: 0001213900-20-002314 · ownership.xml · nonDerivative · entry 8 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 376,642 F8 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.2 to $22.0, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (8) to this Form 4. F2 · ownership.nature: These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| January 31, 2020 Filed Feb 1, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 1,037 | $21.70 | $22,502.90 |
DisclosureSEC source: 0001213900-20-002314 · ownership.xml · nonDerivative · entry 7 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 2,727,561 F8 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.2 to $22.0, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (8) to this Form 4. F1 · ownership.nature: These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| January 30, 2020 Filed Feb 1, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 5,940 | $22.10 | $131,274.00 |
DisclosureSEC source: 0001213900-20-002314 · ownership.xml · nonDerivative · entry 6 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 193,555 F7 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.9 to $22.5, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4. F3 · ownership.nature: These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF"). F5 · ownership.nature: Vivo Opportunity, LLC is the general partner of VOF. The voting members of Vivo Opportunity, LLC are Albert Cha, Gaurav Aggarwal, Shan Fu, Frank Kung and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| January 30, 2020 Filed Feb 1, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 201 | $22.10 | $4,442.10 |
DisclosureSEC source: 0001213900-20-002314 · ownership.xml · nonDerivative · entry 5 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 376,785 F7 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.9 to $22.5, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4. F2 · ownership.nature: These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| January 30, 2020 Filed Feb 1, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 1,459 | $22.10 | $32,243.90 |
DisclosureSEC source: 0001213900-20-002314 · ownership.xml · nonDerivative · entry 4 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 2,728,598 F7 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.9 to $22.5, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4. F1 · ownership.nature: These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| January 29, 2020 Filed Feb 1, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 10,878 | $22.20 | $241,491.60 |
DisclosureSEC source: 0001213900-20-002314 · ownership.xml · nonDerivative · entry 3 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 199,495 F6 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.1 to $22.5, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. F3 · ownership.nature: These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF"). F5 · ownership.nature: Vivo Opportunity, LLC is the general partner of VOF. The voting members of Vivo Opportunity, LLC are Albert Cha, Gaurav Aggarwal, Shan Fu, Frank Kung and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| January 29, 2020 Filed Feb 1, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 369 | $22.20 | $8,191.80 |
DisclosureSEC source: 0001213900-20-002314 · ownership.xml · nonDerivative · entry 2 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 376,986 F6 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.1 to $22.5, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. F2 · ownership.nature: These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| January 29, 2020 Filed Feb 1, 2020 01:00 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 2,673 | $22.20 | $59,340.60 |
DisclosureSEC source: 0001213900-20-002314 · ownership.xml · nonDerivative · entry 1 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See foonotes Disclosed balance after: 2,730,057 F6 · price: The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.1 to $22.5, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. F1 · ownership.nature: These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Edgar Engleman, Albert Cha, Shan Fu and Chen Yu, and none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:32 UTC |
Fust Matthew KDirector
|
Exercise / conversionNon-qualified stock option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001209191-19-061184 · doc4.xml · derivative · entry 3 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,092 Underlying: Common stock · 3,500 shares Expires 2028-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · derivative.exercise_date: Stock option granted March 17, 2018 with one-third vesting on the first anniversary of the grant date and the remainder vesting in a series of twenty-four (24) successive equal monthly installments thereafter. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:32 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 3,500 | $22.50 | $78,750.00 |
DisclosureSEC source: 0001209191-19-061184 · doc4.xml · nonDerivative · entry 2 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,536 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 23:32 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 3,500 | $1.91 | $6,685.00 |
DisclosureSEC source: 0001209191-19-061184 · doc4.xml · nonDerivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| August 13, 2019 Filed Feb 11, 2020 21:09 UTC |
Struthers Richard ScottDirector · President & CEO
|
GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-008280 · doc5.xml · nonDerivative · entry 4 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust 4 Disclosed balance after: 100,000 Read SEC document |
| August 13, 2019 Filed Feb 11, 2020 21:09 UTC |
Struthers Richard ScottDirector · President & CEO
|
GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-008280 · doc5.xml · nonDerivative · entry 3 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust 3 Disclosed balance after: 100,000 Read SEC document |
| August 13, 2019 Filed Feb 11, 2020 21:09 UTC |
Struthers Richard ScottDirector · President & CEO
|
GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-008280 · doc5.xml · nonDerivative · entry 2 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust 2 Disclosed balance after: 100,000 Read SEC document |
| August 13, 2019 Filed Feb 11, 2020 21:09 UTC |
Struthers Richard ScottDirector · President & CEO
|
GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-008280 · doc5.xml · nonDerivative · entry 1 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust 1 Disclosed balance after: 925,805 Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 23:31 UTC |
Struthers Richard ScottDirector · President & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001209191-19-045039 · doc4.xml · derivative · entry 4 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,370 Underlying: Common Stock · 10,000 shares Expires 2028-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48th of the shares subject to the option vested on April 16, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the issuer on each such vesting date. The shares subject to the option are also subject to accelerated vesting as set forth in the employment agreement between the Issuer and the Reporting Person. Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 23:31 UTC |
Struthers Richard ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 10,000 | $1.91 | $19,100.00 |
DisclosureSEC source: 0001209191-19-045039 · doc4.xml · nonDerivative · entry 3 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 1,225,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2019 Filed Jul 16, 2019 23:56 UTC |
Okey StephanieDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $24.15 | $0.00 |
DisclosureSEC source: 0001209191-19-042286 · doc4.xml · derivative · entry 1 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-07-14 F1 · derivative.exercise_date: The option shall vest and become exercisable in three substantially equal annual installments on each of the first three anniversaries of the grant date, subject to continued service as a director through each such vesting date. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 23:03 UTC |
5AM Ventures IV, L.P.Former 10% holder
5AM Co-Investors IV, L.P.Former 10% holder
5AM Partners IV, LLCFormer 10% holder
ROCKLAGE SCOTT MFormer 10% holder
DIEKMAN JOHN DFormer 10% holder
Schwab Andrew J.Former 10% holder
|
SaleCommon Stock | 10,000 | $22.20 | $222,000.00 |
DisclosureSEC source: 0001104659-19-037468 · a4.xml · nonDerivative · entry 2 5AM Ventures IV, L.P. · CIK 0001589315 · Former 10% holder 5AM Co-Investors IV, L.P. · CIK 0001593361 · Former 10% holder 5AM Partners IV, LLC · CIK 0001589314 · Former 10% holder ROCKLAGE SCOTT M · CIK 0001219014 · Former 10% holder DIEKMAN JOHN D · CIK 0001240357 · Former 10% holder Schwab Andrew J. · CIK 0001598549 · Former 10% holder Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footote Disclosed balance after: 94,489 F2 · ownership.nature: These securities are held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Co-Investors IV, and have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 23:03 UTC |
5AM Ventures IV, L.P.Former 10% holder
5AM Co-Investors IV, L.P.Former 10% holder
5AM Partners IV, LLCFormer 10% holder
ROCKLAGE SCOTT MFormer 10% holder
DIEKMAN JOHN DFormer 10% holder
Schwab Andrew J.Former 10% holder
|
SaleCommon Stock | 240,000 | $22.20 | $5,328,000.00 |
DisclosureSEC source: 0001104659-19-037468 · a4.xml · nonDerivative · entry 1 5AM Ventures IV, L.P. · CIK 0001589315 · Former 10% holder 5AM Co-Investors IV, L.P. · CIK 0001593361 · Former 10% holder 5AM Partners IV, LLC · CIK 0001589314 · Former 10% holder ROCKLAGE SCOTT M · CIK 0001219014 · Former 10% holder DIEKMAN JOHN D · CIK 0001240357 · Former 10% holder Schwab Andrew J. · CIK 0001598549 · Former 10% holder Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footote Disclosed balance after: 2,267,797 F1 · ownership.nature: These securities are held by by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 20:08 UTC |
Kaldor Stephen WDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001209191-19-038896 · doc4.xml · derivative · entry 1 Kaldor Stephen W · CIK 0001507502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-06-20 F1 · derivative.exercise_date: The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 20:10 UTC |
Nichols WestonDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001209191-19-038905 · doc4.xml · derivative · entry 1 Nichols Weston · CIK 0001746376 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-06-20 F1 · derivative.exercise_date: The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 20:10 UTC |
Nielsen JackDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001209191-19-038902 · doc4.xml · derivative · entry 1 Nielsen Jack · CIK 0001602402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-06-20 F1 · derivative.exercise_date: The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 20:09 UTC |
Fust Matthew KDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001209191-19-038897 · doc4.xml · derivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-06-20 F1 · derivative.exercise_date: The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 20:07 UTC |
WIERENGA WENDALLDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001209191-19-038894 · doc4.xml · derivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-06-20 F1 · derivative.exercise_date: The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| May 20, 2019 Filed Feb 11, 2020 21:06 UTC |
Krasner Alan SethChief Medical Officer
|
OtherCommon Stock | 1,471 | $14.45 | $21,255.95 |
DisclosureSEC source: 0001209191-20-008272 · doc5.xml · nonDerivative · entry 1 Krasner Alan Seth · CIK 0001435775 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,941 F1 · kind: Shares purchased under Crinetics Pharmaceuticals, Inc 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c). Read SEC document |
| May 20, 2019 Filed Feb 11, 2020 21:04 UTC |
Wilson MarcCFO and Secretary
|
OtherCommon Stock | 1,471 | $14.45 | $21,255.95 |
DisclosureSEC source: 0001209191-20-008269 · doc5.xml · nonDerivative · entry 1 Wilson Marc · CIK 0001702265 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,792 F1 · kind: Shares purchased under Crinetics Pharmaceuticals, Inc 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c). F2 · balance_after: Includes 29,090 shares of restricted stock which remain subject to continued vesting. Read SEC document |
| May 08, 2019 Filed Aug 7, 2019 23:31 UTC |
Struthers Richard ScottDirector · President & CEO
|
GiftCommon Stock | 1,215,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045039 · doc4.xml · nonDerivative · entry 2 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 1,215,805 F1 · kind: Reflects a transfer on May 8, 2019 of 1,215,805 shares by the Reporting Person to the Struthers Family Trust, of which the Reporting Person is the trustee. F1 · balance_after: Reflects a transfer on May 8, 2019 of 1,215,805 shares by the Reporting Person to the Struthers Family Trust, of which the Reporting Person is the trustee. Read SEC document |
| May 08, 2019 Filed Aug 7, 2019 23:31 UTC |
Struthers Richard ScottDirector · President & CEO
|
GiftCommon Stock | 1,215,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045039 · doc4.xml · nonDerivative · entry 1 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects a transfer on May 8, 2019 of 1,215,805 shares by the Reporting Person to the Struthers Family Trust, of which the Reporting Person is the trustee. Read SEC document |
| March 20, 2019 Filed Mar 25, 2019 10:04 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 83,984 | $22.25 | $1,868,644.00 |
DisclosureSEC source: 0001615774-19-004434 · s116878_form4.xml · nonDerivative · entry 3 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 210,373 F3 · ownership.nature: These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF"). F5 · ownership.nature: Vivo Opportunity, LLC is the general partner of VOF. The voting members of Vivo Opportunity, LLC are Frank Kung, Albert Cha, Shan Fu, Gaurav Aggarwal and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes Read SEC document |
| March 20, 2019 Filed Mar 25, 2019 10:04 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 40,407 | $22.25 | $899,055.75 |
DisclosureSEC source: 0001615774-19-004434 · s116878_form4.xml · nonDerivative · entry 2 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 377,355 F2 · ownership.nature: These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Albert Cha, Edgar Engleman, Chen Yu and Shan Fu, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| March 20, 2019 Filed Mar 25, 2019 10:04 UTC |
Vivo Capital VIII, LLC10% owner
Vivo Capital Fund VIII, L.P.10% owner
Vivo Capital Surplus Fund VIII, L.P.10% owner
Vivo Opportunity, LLC10% owner
Vivo Opportunity Fund, L.P.10% owner
|
SaleCommon Stock | 292,609 | $22.25 | $6,510,550.25 |
DisclosureSEC source: 0001615774-19-004434 · s116878_form4.xml · nonDerivative · entry 1 Vivo Capital VIII, LLC · CIK 0001618789 · 10% owner Vivo Capital Fund VIII, L.P. · CIK 0001618788 · 10% owner Vivo Capital Surplus Fund VIII, L.P. · CIK 0001628048 · 10% owner Vivo Opportunity, LLC · CIK 0001728970 · 10% owner Vivo Opportunity Fund, L.P. · CIK 0001726403 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,732,730 F1 · ownership.nature: These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF"). F4 · ownership.nature: Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. The voting members of Vivo LLC are Frank Kung, Albert Cha, Edgar Engleman, Chen Yu and Shan Fu, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 20:48 UTC |
5AM Ventures IV, L.P.10% owner
5AM Co-Investors IV, L.P.10% owner
5AM Partners IV, LLC10% owner
ROCKLAGE SCOTT M10% owner
DIEKMAN JOHN D10% owner
Schwab Andrew J.10% owner
|
SaleCommon Stock | 6,194 | $24.25 | $150,208.84 |
DisclosureSEC source: 0001104659-19-016338 · a4.xml · nonDerivative · entry 2 5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner 5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner 5AM Partners IV, LLC · CIK 0001589314 · 10% owner ROCKLAGE SCOTT M · CIK 0001219014 · 10% owner DIEKMAN JOHN D · CIK 0001240357 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 104,489 F2 · ownership.nature: These securities are held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Co-Investors IV, and have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 20:48 UTC |
5AM Ventures IV, L.P.10% owner
5AM Co-Investors IV, L.P.10% owner
5AM Partners IV, LLC10% owner
ROCKLAGE SCOTT M10% owner
DIEKMAN JOHN D10% owner
Schwab Andrew J.10% owner
|
SaleCommon Stock | 148,645 | $24.25 | $3,604,745.30 |
DisclosureSEC source: 0001104659-19-016338 · a4.xml · nonDerivative · entry 1 5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner 5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner 5AM Partners IV, LLC · CIK 0001589314 · 10% owner ROCKLAGE SCOTT M · CIK 0001219014 · 10% owner DIEKMAN JOHN D · CIK 0001240357 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,507,797 F1 · ownership.nature: These securities are held by by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 22:44 UTC |
Struthers Richard ScottDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 176,250 | $0.00 Strike: $25.19 | $0.00 |
DisclosureSEC source: 0001209191-19-018984 · doc4.xml · derivative · entry 1 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,250 Underlying: Common Stock · 176,250 shares Expires 2029-03-07 F1 · derivative.exercise_date: The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the Vesting Commencement Date of March 8, 2019. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 22:43 UTC |
Wilson MarcChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 56,250 | $0.00 Strike: $25.19 | $0.00 |
DisclosureSEC source: 0001209191-19-018983 · doc4.xml · derivative · entry 1 Wilson Marc · CIK 0001702265 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 56,250 shares Expires 2029-03-07 F1 · derivative.exercise_date: The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the Vesting Commencement Date of March 8, 2019. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 22:42 UTC |
Krasner Alan SethChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 56,250 | $0.00 Strike: $25.19 | $0.00 |
DisclosureSEC source: 0001209191-19-018982 · doc4.xml · derivative · entry 1 Krasner Alan Seth · CIK 0001435775 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 56,250 shares Expires 2029-03-07 F1 · derivative.exercise_date: The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the Vesting Commencement Date of March 8, 2019. Read SEC document |
| February 20, 2019 Filed Feb 23, 2019 01:06 UTC |
5AM Ventures IV, L.P.10% owner
5AM Co-Investors IV, L.P.10% owner
5AM Partners IV, LLC10% owner
ROCKLAGE SCOTT M10% owner
DIEKMAN JOHN D10% owner
Schwab Andrew J.10% owner
|
OtherCommon Stock | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-010154 · a4.xml · nonDerivative · entry 11 5AM Ventures IV, L.P. · CIK 0001589315 · 10% owner 5AM Co-Investors IV, L.P. · CIK 0001593361 · 10% owner 5AM Partners IV, LLC · CIK 0001589314 · 10% owner ROCKLAGE SCOTT M · CIK 0001219014 · 10% owner DIEKMAN JOHN D · CIK 0001240357 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,723 F19 · kind: Represents the receipt of shares of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution by Co-Investors IV to the Scott M. Rocklage Trust u/d/t/ dated October 22, 2015; Trustees: Scott M. Rocklage and Patty B. Rocklage ("Rocklage Trust II"). F20 · ownership.nature: These securities are held of record by the Rocklage Trust II. Dr. Rocklage is a trustee and beneficiary of the Rocklage Trust II and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.